CLINICAL_TRIALS
trial_result
· 2014-08-11
Clinical Trial Update: A Clinical Study of Intravenous Immunoglobulin [Phase 3]
Summary
Phase 3 clinical trial evaluating intravenous immunoglobulin for immunologic deficiency syndromes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: FFF Enterprises | Conditions: Immunologic Deficiency Syndromes | Phase 3 | Status: COMPLETED